AOD 9604 does not raise blood sugar, does not cause insulin resistance, and does not interfere with tirzepatide insulin-sensitizing effects
Parenteral administration is recommended for patients who are unable to take oral medications, such as before or after surgery, suffering from prolonged illness, or due to the inability to absorb vitamins in the gastrointestinal system
AOD9604 acts directly on fat metabolism but doesnt meaningfully raise HGH or IGF1 levels (human safety data)
Glow is 70mg (3 peptides), Klow is 80mg (4 peptides)
An IV Drip slowly infuses carefully measured IV Fluids and nutrients through a catheter placed in a vein, using top-quality IV Tubing and equipment
This is where compounds like GHK-Cu become interesting